These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29100804)

  • 61. Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases.
    Tanji K; Maruyama A; Odagiri S; Mori F; Itoh K; Kakita A; Takahashi H; Wakabayashi K
    J Neuropathol Exp Neurol; 2013 Jan; 72(1):18-28. PubMed ID: 23242280
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Letter to the editor on: Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions by Park et al. (2022).
    Luo H; Gustavsson EK; Macpherson H; Dominik N; Zhelcheska K; Montgomery K; Anderson C; Yau WY; Efthymiou S; Turner C; DeTure M; Dickson DW; Josephs KA; Revesz T; Lashley T; Halliday G; Rowe DB; McCann E; Blair I; Lees AJ; Tienari PJ; Suomalainen A; Molina-Porcel L; Kovacs GG; Gelpi E; Hardy J; Haltia MJ; Tucci A; Jaunmuktane Z; Ryten M; Houlden H; Chen Z
    Acta Neuropathol Commun; 2024 Jan; 12(1):2. PubMed ID: 38167323
    [No Abstract]   [Full Text] [Related]  

  • 63. Mechanism and structural diversity of exoribonuclease-resistant RNA structures in flaviviral RNAs.
    MacFadden A; O'Donoghue Z; Silva PAGC; Chapman EG; Olsthoorn RC; Sterken MG; Pijlman GP; Bredenbeek PJ; Kieft JS
    Nat Commun; 2018 Jan; 9(1):119. PubMed ID: 29317714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synaptic control of mRNA translation by reversible assembly of XRN1 bodies.
    Luchelli L; Thomas MG; Boccaccio GL
    J Cell Sci; 2015 Apr; 128(8):1542-54. PubMed ID: 25736288
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Xrn1 Exoribonuclease-An Intrinsic Marker of Yeast Population Growth.
    Grousl T; Vomastek T
    Front Biosci (Elite Ed); 2024 Jan; 16(1):1. PubMed ID: 38538525
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.
    Josephs KA; Ahmed Z; Katsuse O; Parisi JF; Boeve BF; Knopman DS; Petersen RC; Davies P; Duara R; Graff-Radford NR; Uitti RJ; Rademakers R; Adamson J; Baker M; Hutton ML; Dickson DW
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):142-51. PubMed ID: 17278999
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Engineered viral RNA decay intermediates to assess XRN1-mediated decay.
    Russo J; Mundell CT; Charley PA; Wilusz C; Wilusz J
    Methods; 2019 Feb; 155():116-123. PubMed ID: 30521847
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington's model mice.
    Kurosawa M; Matsumoto G; Kino Y; Okuno M; Kurosawa-Yamada M; Washizu C; Taniguchi H; Nakaso K; Yanagawa T; Warabi E; Shimogori T; Sakurai T; Hattori N; Nukina N
    Hum Mol Genet; 2015 Feb; 24(4):1092-105. PubMed ID: 25305080
    [TBL] [Abstract][Full Text] [Related]  

  • 69. SUMOylation substrates in neuronal intranuclear inclusion disease.
    Takahashi-Fujigasaki J; Arai K; Funata N; Fujigasaki H
    Neuropathol Appl Neurobiol; 2006 Feb; 32(1):92-100. PubMed ID: 16409557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases.
    Uchihara T; Tanaka J; Funata N; Arai K; Hattori T
    Acta Neuropathol; 2003 Feb; 105(2):103-8. PubMed ID: 12536220
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1.
    Umahara T; Uchihara T; Yagishita S; Nakamura A; Tsuchiya K; Iwamoto T
    Neurosci Lett; 2007 Mar; 414(2):130-5. PubMed ID: 17224237
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protein composition of the intranuclear inclusions of FXTAS.
    Iwahashi CK; Yasui DH; An HJ; Greco CM; Tassone F; Nannen K; Babineau B; Lebrilla CB; Hagerman RJ; Hagerman PJ
    Brain; 2006 Jan; 129(Pt 1):256-71. PubMed ID: 16246864
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
    Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
    Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dis3l2-Mediated Decay Is a Quality Control Pathway for Noncoding RNAs.
    Pirouz M; Du P; Munafò M; Gregory RI
    Cell Rep; 2016 Aug; 16(7):1861-73. PubMed ID: 27498873
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy.
    Tanikawa S; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2012 Oct; 527(1):16-21. PubMed ID: 22947304
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ubiquitin-positive tau-negative intraneuronal inclusions in dementia with motor neuron disease: The 50th Anniversary of Japanese Society of Neuropathology.
    Okamoto K
    Neuropathology; 2010 Oct; 30(5):486-9. PubMed ID: 20500451
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structural features of an Xrn1-resistant plant virus RNA.
    Dilweg IW; Gultyaev AP; Olsthoorn RC
    RNA Biol; 2019 Jun; 16(6):838-845. PubMed ID: 30951405
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neuronal Intranuclear Inclusion Disease presenting as juvenile Parkinsonism.
    Wiltshire KM; Dunham C; Reid S; Auer RN; Suchowersky O
    Can J Neurol Sci; 2010 Mar; 37(2):213-8. PubMed ID: 20437931
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chimeric Flaviviral RNA-siRNA Molecules Resist Degradation by The Exoribonuclease Xrn1 and Trigger Gene Silencing in Mammalian Cells.
    Harvey C; Klassa S; Finol E; Hall J; Hill AC
    Chembiochem; 2021 Nov; 22(21):3099-3106. PubMed ID: 34431199
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.
    Astuti D; Morris MR; Cooper WN; Staals RH; Wake NC; Fews GA; Gill H; Gentle D; Shuib S; Ricketts CJ; Cole T; van Essen AJ; van Lingen RA; Neri G; Opitz JM; Rump P; Stolte-Dijkstra I; Müller F; Pruijn GJ; Latif F; Maher ER
    Nat Genet; 2012 Feb; 44(3):277-84. PubMed ID: 22306653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.